Universal Ibogaine (FRA:JC4) Piotroski F-Score: 0 (As of Jul. 11, 2026)


What is Universal Ibogaine Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Universal Ibogaine has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Universal Ibogaine's Piotroski F-Score or its related term are showing as below:

Universal Ibogaine  (FRA:JC4) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Universal Ibogaine Piotroski F-Score Related Terms


Universal Ibogaine Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Universal Ibogaine's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universal Ibogaine Piotroski F-Score Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23 Jul24
Piotroski F-Score
Get a 7-Day Free Trial 1.00 1.00 4.00 2.00 4.00

Universal Ibogaine Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 4.00 3.00 1.00 2.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Apr25) TTM:Last Year (Apr24) TTM:
Net Income was -0.51 + -0.232 + -0.204 + -0.042 = €-0.99 Mil.
Cash Flow from Operations was -0.057 + -0.164 + -0.136 + -0.07 = €-0.43 Mil.
Revenue was 0.376 + 0.286 + 0.25 + 0.446 = €1.36 Mil.
Gross Profit was 0.376 + 0.286 + 0.25 + 0.446 = €1.36 Mil.
Average Total Assets from the begining of this year (Apr24)
to the end of this year (Apr25) was
(3.625 + 3.034 + 2.728 + 2.54 + 2.551) / 5 = €2.8956 Mil.
Total Assets at the begining of this year (Apr24) was €3.63 Mil.
Long-Term Debt & Capital Lease Obligation was €1.10 Mil.
Total Current Assets was €0.50 Mil.
Total Current Liabilities was €1.28 Mil.
Net Income was -0.184 + -0.144 + -0.152 + -0.588 = €-1.07 Mil.

Revenue was 0.383 + 0.446 + 0.403 + 0.366 = €1.60 Mil.
Gross Profit was 0.383 + 0.446 + 0.403 + 0.366 = €1.60 Mil.
Average Total Assets from the begining of last year (Apr23)
to the end of last year (Apr24) was
(3.974 + 3.765 + 3.812 + 3.835 + 3.625) / 5 = €3.8022 Mil.
Total Assets at the begining of last year (Apr23) was €3.97 Mil.
Long-Term Debt & Capital Lease Obligation was €1.80 Mil.
Total Current Assets was €0.50 Mil.
Total Current Liabilities was €0.77 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Universal Ibogaine's current Net Income (TTM) was -0.99. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Universal Ibogaine's current Cash Flow from Operations (TTM) was -0.43. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Apr24)
=-0.988/3.625
=-0.27255172

ROA (Last Year)=Net Income/Total Assets (Apr23)
=-1.068/3.974
=-0.26874685

Universal Ibogaine's return on assets of this year was -0.27255172. Universal Ibogaine's return on assets of last year was -0.26874685. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Universal Ibogaine's current Net Income (TTM) was -0.99. Universal Ibogaine's current Cash Flow from Operations (TTM) was -0.43. ==> -0.43 > -0.99 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Apr25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Apr24 to Apr25
=1.097/2.8956
=0.37885067

Gearing (Last Year: Apr24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Apr23 to Apr24
=1.797/3.8022
=0.47262111

Universal Ibogaine's gearing of this year was 0.37885067. Universal Ibogaine's gearing of last year was 0.47262111. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Apr25)=Total Current Assets/Total Current Liabilities
=0.499/1.281
=0.38953942

Current Ratio (Last Year: Apr24)=Total Current Assets/Total Current Liabilities
=0.496/0.765
=0.64836601

Universal Ibogaine's current ratio of this year was 0.38953942. Universal Ibogaine's current ratio of last year was 0.64836601. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Universal Ibogaine's number of shares in issue this year was 308.611. Universal Ibogaine's number of shares in issue last year was 284.452. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=1.358/1.358
=1

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=1.598/1.598
=1

Universal Ibogaine's gross margin of this year was 1. Universal Ibogaine's gross margin of last year was 1. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Apr24)
=1.358/3.625
=0.37462069

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Apr23)
=1.598/3.974
=0.40211374

Universal Ibogaine's asset turnover of this year was 0.37462069. Universal Ibogaine's asset turnover of last year was 0.40211374. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Universal Ibogaine has an F-score of 2. It is a bad or low score, which usually implies poor business operation.


Universal Ibogaine Business Description

Address C/o Cas Corporate Governance Services Inc, 815 - 8th Avenue South west, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc is in the initial stages of implementing and financing its business plan, which is to develop a network of addiction treatment clinics and to undertake a planned clinical trial for research in Canada into the use of ibogaine, a natural plant-based substance, for addiction treatment. Its mission is to redefine the addiction recovery experience, providing those living with addiction the best possible recovery.